Where Strategic IP Decisions Matter Most
Hylton-Rodic Law is a Washington, D.C.–based intellectual property firm.
We work with innovative companies in scientifically complex industries, where intellectual property decisions shape commercialization, competitive advantage, investment, market access, and long-term business success. Although the technologies differ, the challenge is often the same: making strategic IP decisions today that continue to support the business tomorrow.
Strategic intellectual property counsel
Building durable competitive advantage.
We help innovative companies make informed decisions about what to build, what to protect, and how intellectual property supports long-term business objectives.
How we think
IP is a series of business decisions.
Those decisions influence commercialization, competitive advantage, investment, market access, and long-term growth. Start with the question your business is facing.
01 What should we protect?
Identify the inventions, platforms, and commercial differentiators that deserve investment before filing decisions are made.
Explore patent portfolio strategy →02 Where should we file?
Align domestic and international protection with markets, competitors, partnerships, and realistic business priorities.
Explore global patent strategy →03 Can we operate with confidence?
Understand third-party patent risk before committing capital, entering a market, or launching a product.
Explore patent risk strategy →04 Is our portfolio supporting growth?
Review whether today's portfolio still supports tomorrow's products, licensing plans, investment, and market position.
Explore portfolio strategy →Where strategic IP decisions matter most
Scientific depth. Commercial perspective.
Different technologies. A shared need to make IP decisions today that continue to support the business tomorrow.
Life Sciences
Biotechnology, diagnostics, and personalized medicine.
Explore 02Pharmaceuticals & Therapeutics
Drug discovery, formulations, and delivery systems.
Explore 03Chemistry, Materials & Advanced Technologies
Specialty chemicals, advanced materials, and battery technologies.
Explore 04Medical Devices & Diagnostics
Medical devices, diagnostics, and integrated technologies.
Explore 05Universities & Technology Transfer
Research commercialization, licensing, and technology transfer.
Explore 06Startups & Emerging Companies
Strategic guidance from early innovation through commercialization.
ExploreFeatured strategic conversation
Who captures the value of AI-discovered therapeutics?
Explore the ownership, inventorship, defensibility, and commercial questions shaping the next generation of discovery.
Explore the conversation →Freedom to operate
Know the landscape before committing capital.
Read more →Commercial readiness
Build a portfolio that holds up when it matters.
Read more →Your next strategic decision
What could a stronger IP strategy open for your business?
Let's discuss the decisions shaping your next stage of innovation.
Start a conversation
-
![]()
Chemistry-Driven, Materials & Advanced Technologies
-
![]()
Life Sciences
-
![]()
Medical Devices & Diagnostics
-
![]()
Pharmaceuticals & Therapeutics
-
![]()
Startups & Emerging Companies
-
![]()
Universities & Technology Transfer
Featured Insights
-
How Should Your IP Strategy Evolve as AI Accelerates Drug Discovery?
AI is transforming how new therapies are discovered. Explore strategic perspectives on protecting innovation while supporting long-term commercial growth.
-
Could Existing Patents Delay Your Next Product Launch?
A Freedom-to-Operate (FTO) analysis can help identify potential patent risks before commercialization, supporting more informed business decisions.
-
Will Your Patent Portfolio Support Your Business as It Grows?
Strong IP strategy extends beyond patent filings. Learn how thoughtful portfolio planning can strengthen commercialization, partnerships, and long-term growth.
Hello, World!
